Effects of high- and low-dose amiodarone on mortality, left ventricular remodeling, and hemodynamics in rats with experimental myocardial infarction

Journal of Cardiovascular Pharmacology

Volumn 44, Issue 6, 2004, Pages 627-630

  Hu, Kai ^a   Gaudron, Peter ^b   Ertl, Georg ^a,c  

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^b Krankenhaus St Georg   (Germany)

^c UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Amiodarone; Myocardial infarction; Rats; Remodeling

Indexed keywords

AMIODARONE; PLACEBO; POTASSIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; CORONARY ARTERY LIGATION; FEMALE; HEART ARREST; HEART HEMODYNAMICS; HEART INFARCTION; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE PRESSURE; HEART LEFT VENTRICLE VOLUME; HEART RATE; HEART STROKE VOLUME; HEART VENTRICLE REMODELING; MORTALITY; NONHUMAN; PRIORITY JOURNAL; RAT; SURVIVAL RATE;

AMIODARONE; ANIMALS; ANTI-ARRHYTHMIA AGENTS; BODY WEIGHT; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEMODYNAMIC PROCESSES; MYOCARDIAL INFARCTION; MYOCARDIUM; ORGAN SIZE; RATS; RATS, WISTAR; SURVIVAL ANALYSIS; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 9744238756     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200412000-00001     Document Type: Article

References (12)

1. Singh SN, Fletcher RD. Class III drugs and congestive heart failure: focus on the congestive heart failure-survival trial of antiarrhythmic therapy. Am J Cardiol. 1999;84:103R-108R.
2. Kodama I, Kamiya K, Toyama J. Cellular electropharmacology of amiodarone. Cardiovasc Res. 1997;35:13-29.
3. Charlier R. Cardiac actions in the dog of a new antagonist of adrenergic excitation which does not produce competitive blockade of adrenoceptors. Br J Pharmacol. 1970;39:668-674.
4. ATMA Investigators. Effect of prophylactic amiodarone on mortality after acute myocardial infarction and in congestive heart failure: meta-analysis of individual data from 6500 patients in randomised trials. Amiodarone Trials Meta- Analysis Investigators. Lancet. 1997;350:1417-1424.
5. Hu K, Gaudron P, Ertl G. Long-term effects of beta-adrenergic blocking agent treatment on hemodynamic function and left ventricular remodeling in rats with experimental myocardial infarction: importance of timing of treatment and infarct size. J Am Coll Cardiol. 1998;31:692-700.
6. Hu K, Nauman A, Fraccarollo D, et al. Heart rate reduction by zatebradine reduces infarct size and mortality but promotes remodeling in rats with experimental myocardial infarction. Am J Physiol. 2004;(in press).
7. Singh BN. Antiarrhythmic actions of amiodarone: a profile of a paradoxical agent. Am J Cardiol. 1996;78:41-53.
8. Gaudron P, Hu K, Schamberger R, et al. Effect of endurance training early or late after coronary artery occlusion on left ventricular remodeling, hemodynamics, and survival in rats with chronic transmural myocardial infarction. Circulation. 1994;89:402-412.
9. Fishbein MC, Lei LQ, Rubin SA. Long-term propranolol administration alters myocyte and ventricular geometry in rat hearts with and without infarction. Circulation. 1988;78:369-375.
10. Oh BH, Ono S, Gilpin E, et al. Altered left ventricular remodeling with beta-adrenergic blockade and exercise after coronary reperfusion in rats. Circulation. 1993;87:608-616.
11. Opitz CF, Finn PV, Pfeffer MA, et al. Effects of reperfusion on arrhythmias and death after coronary artery occlusion in the rat: increased electrical stability independent of myocardial salvage. J Am Coll Cardiol. 1998;32:261-267.
12. Di Matola T, D'Ascoli F, Fenzi G, et al. Amiodarone induces cytochrome c release and apoptosis through an iodine-independent mechanism. J Clin Endocrinol Metab. 2000;85:4323-4330.